Transcranial Magnetic Stimulators Market is Expected To Reach USD 1.82 Billion By 2027 at a CAGR of 8.3%

14 Sep 2022
www.biospace.com
VaccineAcquisitionCollaborate
The increase in the prevalence of Parkinson's and Alzheimer's diseases and rising awareness regarding the transcranial magnetic stimulators are driving the market. The global Transcranial Magnetic Stimulators Market is forecast to reach USD 1.82 Billion by 2027, according to a new report by Reports and Data. Transcranial magnetic stimulation is a non-invasive surgery widely used for the treatment of the brain and neurological diseases. It uses a magnetic field to stimulate nerve cells in the brain and reduce chronic pain. The demand for the transcranial magnetic stimulator has increased owing to the rising prevalence of neurological diseases. Increase in awareness regarding health, growing population, and changing lifestyle has further driven the market for transcranial magnetic stimulation. Neurological and mental disorders are becoming quite common across the globe, owing to the increased life expectancy and rapidly changing lifestyle. Access Free sample PDF Copy of the Report (To Understand the Complete Structure of this Report [Summary + TOC]) @ There are several medical factors influencing the growth of the transcranial magnetic stimulator market directly. Neurological disorders are the leading cause of disability and death across the globe currently. Increase in the patient suffering from Alzheimer’s, Multiple Sclerosis, Cerebrovascular, Parkinson’s, and Epilepsy, provide ample growth opportunities for the market. Europe is the second-largest market witnessing moderate growth for the transcranial magnetic stimulator market. The governments in Europe are coming up with some of the initiatives to educate and to raise awareness regarding the neurological diseases. One of the initiatives, such as the European Parkinson’s Disease Association, is actively supporting research and development by campaigning to generate awareness and provide medication to patients. Further key findings from the report suggest Deep transcranial magnetic stimulation is a non-invasive, non-drug, yet effective treatment for depression patients. It is a type of brain stimulation technique where pulsed magnetic fields are generated by a coil placed on the scalp. This current essentially activates the neuronal circuits at the stimulation site, resulting in symptom improvement. Transcranial magnetic stimulation uses magnetic fields to invigorate nerve cells in the brain to enhance symptoms of depression. It is generally used when different forms of depression treatments haven't been effective. This treatment for depression involves delivering repetitive magnetic pulses, so it's called repetitive TMS or rTMS. Depression can be treated, but for some people, standard treatments aren't effective. Repetitive TMS is used when standard treatments such as medications and psychotherapy don't work. Hospitals held the largest market share owing to the growing investments in the healthcare sector by the government. Surge in the number of hospitals across the globe and rapid modernization of it in the emerging nations are propelling the demand of the segment in the market. Hospitals are generally equipped with efficient professionals at all times to help patients with the procedure. Asia Pacific is anticipated grow at the fastest CAGR of 9.5% during the forecast period. Growing healthcare tourism, changing lifestyle, increase in the prevalence of chronic diseases, heavy investments in the transcranial magnetic stimulator, and a large number of product launches are some of the key factors supporting the growth in the region. The ongoing pandemic is significantly changing the dynamics of the pharma and healthcare sector. Various countries are facing challenges such as shortage of medicines, vaccines, healthcare devices in hospitals. This is expected to open lucrative growth opportunities for market players in the coming years. For Inquiry Before Buying @ Competitive Landscape: The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, merger and acquisitions, collaborations, and joint ventures to gain robust footing in the market. Top Companies Profiled in the Report: Brainsway, eNeura, MagVenture, Neurosoft, Dr. Langer Medical, MAG & More, Remed, Nexstim, Yiruide, and Neuronetics Inc., among others. Browse Full Report Description with Research Methodology, Table of Content and Infographics @ Transcranial Magnetic Stimulators Market Segmentation: Type Outlook (Revenue, USD Million; 2016-2027) Deep Transcranial Magnetic Stimulator (dTMS) Repetitive Transcranial Magnetic Stimulator Application Outlook (Revenue, USD Million; 2016-2027) Alzheimer's Disease Parkinson's Disease Depression Disease Epilepsy Disease End-User Outlook (Revenue, USD Million; 2016-2027) Hospitals Ambulatory Surgical Centers Clinics Regional Outlook: North America (U.S., Canada, Mexico) Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe) Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific) Latin America (Brazil, Rest of LATAM) Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa) Ask for Customize Research Report @ This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth. Explore More Industry Research by Reports and Data: Oncology Information System Market Analysis, By Products and Services (Patient Information System, Consulting Services, Implementation System), By Application, By End Use, and Region, Forecasts To 2028 - Download PDF Brochure Embolic Protection Devices Market Analysis, By Device (Occlusion Devices, Distal Filter Devices), By Material (Nitinol, Polyurethane), By Indication (Cardiovascular Diseases, Neurovascular Diseases), By End-Use (Ambulatory Surgical Centers, Hospitals), Forecasts To 2028 - Download PDF Brochure Ophthalmic Lasers Market Analysis, By Product (Diode lasers, Excimer Lasers, Femtosecond Lasers Nd:Yag Lasers ), By End Use (Hospitals, Eye Clinics, Ambulatory Surgical Centers), By Application ( Cataract Treatment), Region Outlook, Forecasts To 2028 - Download PDF Brochure Sterility Testing Market Analysis, By Test Method (Membrane Filtration System Sterility Test), By Application (Raw Materials, Pharmaceutical Preparations), By End-Use (Biopharmaceutical and Pharmaceutical Companies, Cell Banks), And Segment Forecasts To 2028 - Download PDF Brochure About Reports and Data Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors. Contact Us: John W Head of Business Development Reports And Data | Web: Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com LinkedIn | Twitter | Blogs Read the innovative blog at Check out our upcoming research report at For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update:
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.